| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/00365540902721368 |
| P698 | PubMed publication ID | 19173129 |
| P2093 | author name string | Lennart E Nilsson | |
| Göran Kronvall | |||
| Carina Claesson | |||
| Mats Walder | |||
| Mikael Sörberg | |||
| P2860 | cites work | Functional, biophysical, and structural bases for antibacterial activity of tigecycline | Q24548264 |
| Antimicrobial activity and spectrum of the new glycylcycline, GAR-936 tested against 1,203 recent clinical bacterial isolates | Q28374993 | ||
| Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surve | Q33181940 | ||
| Glycopeptide resistance in coagulase-negative staphylococci | Q34006954 | ||
| Aminoglycoside resistance in enterococci | Q34033627 | ||
| Antimicrobial susceptibility among pathogens collected from hospitalized patients in the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial | Q34569412 | ||
| Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia | Q34783668 | ||
| Protein binding and serum bactericidal activities of vancomycin and teicoplanin | Q35117545 | ||
| Prevalence of inducible clindamycin resistance in staphylococcal isolates at a Korean tertiary care hospital | Q37205609 | ||
| Antibiotic resistance among enterococci causing endocarditis in the UK: analysis of isolates referred to a reference laboratory | Q38646012 | ||
| Activities of the glycylcycline tigecycline (GAR-936) against 1,924 recent European clinical bacterial isolates | Q39730764 | ||
| Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme | Q40512351 | ||
| Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent oxyrase to standardize the test method | Q42085642 | ||
| Validation and reproducibility assessment of tigecycline MIC determinations by Etest | Q42412999 | ||
| Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems. | Q43648071 | ||
| Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals | Q44299877 | ||
| High antibiotic susceptibility among bacterial pathogens in Swedish ICUs. Report from a nation-wide surveillance program using TA90 as a novel index of susceptibility | Q44786348 | ||
| Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. | Q45003082 | ||
| In vitro evaluation of tigecycline and comparative agents in 3049 clinical isolates: 2001 to 2002. | Q46420086 | ||
| Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit | Q46654689 | ||
| Epidemiological MIC cut-off values for tigecycline calculated from Etest MIC values using normalized resistance interpretation | Q46892790 | ||
| Distribution of resistant gram-positive organisms across the census regions of the United States and in vitro activity of tigecycline, a new glycylcycline antimicrobial | Q46951254 | ||
| Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study | Q48920995 | ||
| Prevalence of vancomycin-resistant enterococci in Europe. | Q54023817 | ||
| Susceptibility of gram-positive cocci from 25 UK hospitals to antimicrobial agents including linezolid. The Linezolid Study Group. | Q54027855 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 171-181 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | Infectious Diseases | Q7429961 |
| P1476 | title | Antimicrobial activity of tigecycline and comparative agents against clinical isolates of staphylococci and enterococci from ICUs and general hospital wards at three Swedish university hospitals | |
| P478 | volume | 41 |
| Q35004010 | Antipsychotics and the gut microbiome: olanzapine-induced metabolic dysfunction is attenuated by antibiotic administration in the rat |
| Q44274180 | High incidence of post-injury pneumonia in intensive care-treated trauma patients. |
| Q34156144 | Pathogens in the lower respiratory tract of intensive care unit patients: impact of duration of hospital care and mechanical ventilation |
Search more.